VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00202 Package ID: USCOURTS-cofc-1_18-vv-00202 Petitioner: Milan Harper Filed: 2018-02-08 Decided: 2021-11-09 Vaccine: Tdap Vaccination date: 2016-12-29 Condition: Shoulder Injury Related to Vaccine Administration (SIRVA) Outcome: compensated Award amount USD: 96185 AI-assisted case summary: Milan Harper filed a petition for compensation under the National Vaccine Injury Compensation Program on February 8, 2018, alleging a Shoulder Injury Related to Vaccine Administration (SIRVA) resulting from a tetanus-diphtheria-acellular pertussis (Tdap) vaccine she received on December 29, 2016. At the time of vaccination, Ms. Harper was 31 weeks pregnant. Her shoulder pain began within 48 hours of the vaccination and progressed to the point where she could not lift her left arm. She was hospitalized for four days. Subsequently, she received intermittent treatment for her shoulder injury for approximately three years, including orthopedic evaluations, a steroid injection, and recommendations for surgery and physical therapy, though she did not undergo surgery. The respondent, the Secretary of Health and Human Services, initially argued that the petitioner failed to meet the threshold severity requirement of suffering residual effects for more than six months. However, following a Finding of Fact by Chief Special Master Brian H. Corcoran on October 28, 2020, that the petitioner did meet this requirement, the respondent elected not to defend the case. The respondent's Supplemental Rule 4(c) Report indicated that the Division of Injury Compensation Programs determined the petitioner's medical course was consistent with SIRVA as defined by the Vaccine Injury Table, noting no recent history of shoulder pain or dysfunction, onset within 48 hours of vaccination, pain limited to the vaccinated shoulder, and no other identified condition to explain the pain. On November 16, 2020, Chief Special Master Corcoran issued a Ruling on Entitlement, finding the petitioner entitled to compensation. The parties subsequently stipulated to $4,185.03 for unreimbursed expenses but disputed the amount for pain and suffering. Following a hearing on September 24, 2021, Chief Special Master Corcoran issued a Decision Awarding Damages on November 9, 2021. He awarded Ms. Harper $92,000.00 for actual pain and suffering, bringing the total award to $96,185.03. In determining the pain and suffering award, the Special Master considered the severity and duration of the injury, noting the petitioner's initial severe pain, hospitalization, and intermittent treatment over three years. He also considered affidavits detailing the impact of the pain on her daily life and care for her children. However, he also factored in gaps in treatment and the lack of more intensive medical interventions, such as surgery or extensive physical therapy, which led him to award an amount lower than requested by the petitioner but higher than recommended by the respondent. Petitioner was represented by Michael Patrick Milmoe of the Law Offices of Leah V. Durant, PLLC, and respondent was represented by Colleen Clemons Hartley of the U.S. Department of Justice. Theory of causation field: Milan Harper, age 29.75, received a Tdap vaccine on December 29, 2016, and subsequently developed Shoulder Injury Related to Vaccine Administration (SIRVA). The injury met the Vaccine Injury Table criteria, with onset within 48 hours, localized to the vaccination site, and no other identified cause. The respondent elected not to defend the case after a Finding of Fact established the injury's severity for more than six months. The parties stipulated to $4,185.03 for unreimbursed expenses. Chief Special Master Brian H. Corcoran awarded $92,000.00 for pain and suffering, totaling $96,185.03. The decision was issued on November 9, 2021. Petitioner was represented by Michael Patrick Milmoe and respondent by Colleen Clemons Hartley. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_18-vv-00202-0 Date issued/filed: 2020-12-02 Pages: 7 Docket text: PUBLIC ORDER/RULING (Originally filed: 10/28/2020) regarding 51 Findings of Fact & Conclusions of Law, Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-202V UNPUBLISHED MILAN HARPER, Chief Special Master Corcoran Petitioner, Filed: October 28, 2020 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Findings of Fact; Statutory Six Month HUMAN SERVICES, Requirement; Tetanus Diphtheria acellular Pertussis (Tdap) Vaccine; Respondent. Shoulder Injury Related to Vaccine Administration (SIRVA) Michael Patrick Milmoe, Law Offices of Leah V. Durant, PLLC, Washington, DC, for petitioner. Mark Kim Hellie, U.S. Department of Justice, Washington, DC, for respondent. FINDINGS OF FACT1 On February 8, 2018, Milan Harper filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a Shoulder Injury Related to Vaccine Administration (“SIRVA”) as a result of her December 29, 2016 Tetanus Diphtheria acellular Pertussis (“Tdap”) vaccination. Petitioner alleges a Table case for SIRVA. 1 Because this unpublished fact ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the fact ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 2 of 7 Petition at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters. For the reasons discussed below, I find that Petitioner suffered the residual effects of her alleged vaccine-related injury for more than six months after vaccination, as required by Section 11(c)(1)(D)(i) of the Vaccine Act. I. Relevant Procedural History On March 31, 2019, Respondent filed a Status Report indicating that he had completed review of the evidence filed in this case and wished to engage in settlement discussions. ECF No. 25. By October 8, 2019, however, the parties had determined that further settlement discussions would not be fruitful, and proposed instead that Respondent file a Rule 4 (c) Report within 60 days providing his position in this case. ECF No. 35. On December 9, 2019, Respondent filed his Rule 4(c) Report arguing that Petitioner’s case should be dismissed for failure to satisfy the “threshold severity requirement” that Petitioner suffered the residual effects of her alleged vaccine-related injury for more than six months after vaccination. ECF No. 36. On January 6, 2020, I convened a Rule 5 Status Conference at the request of the parties. ECF No. 37. During the conference, I proposed a preliminary finding that Petitioner would likely be able to establish entitlement to compensation, through satisfaction of the Table requirements for a SIRVA case. 42 C.F.R. § 100.3(c)(10) (2017). Additionally, I made a second preliminary finding that Petitioner has suffered the sequela of her injury for more than six months. Id. Thereafter, Respondent indicated he no longer intended to defend this case and proposed filing an amended Rule 4(c) Report within 30 days the filing of Petitioner’s outstanding medical records. ECF No. 38. However, after additional consideration, Respondent requested I issue formal findings of fact and conclusion of law regarding the severity issue, after which Respondent would file his supplemental Rule 4(c) Report. ECF No. 42. A status conference was convened on April 27, 2020. It was agreed that I would issue formal findings of fact and conclusions of law in regard to the severity requirement, and that Respondent would file his supplemental Rule 4 Report within 14 days thereafter. ECF No. 43. Subsequently, Petitioner filed a supplemental affidavit, additional documentation, and updated medical records. Exs. 17-21. On July 16, 2020, Petitioner filed a Status Report indicating that the record is complete and requesting I rule on the severity requirement issue. ECF No. 49. 2 Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 3 of 7 II. Issue Whether Petitioner suffered the residual effects of her alleged vaccine-related injury for more than six months after vaccination, as required by Section 11(c)(1)(D)(i) of the Vaccine Act. III. Authority The purpose of the Vaccine Act is to award “vaccine-injured persons quickly, easily, and with certainty and generosity.” Weddel v. Sec’y of Health & Human Servs., 100 F.3d 929, 932 (Fed. Cir. 1996) (quoting H.R. Rep. No. 99-908, at 3 (1986)). The Act was meant to remedy the problem that “for the relatively few who are injured by vaccines – through no fault of their own – the opportunities for redress and restitution [were] limited, time consuming, expensive, and often unanswered.” Cloer v. Sec’y of Health & Human Servs., 654 F.3d 1322, 1325 (Fed. Cir. 2011) (en banc) (quoting H.R. Rep. No. 99-908, at 6 (1986)). As a result, the program places some emphasis on speed and efficiency, especially in close cases. The Vaccine Act requires that a Petitioner demonstrate that “residual effects or complications” of a vaccine related injury continued for more than six months. Section 11(c)(1)(D)(i). A Petitioner cannot establish the length or ongoing nature of an injury merely through self-assertion unsubstantiated by medical records or medical opinion. Section 13(a)(1). In particular, a petitioner must prove, by a preponderance of the evidence, the matters required in the petition by Section 11(c)(1). A special master must consider, but is not bound by, any diagnosis, conclusion, judgment, test result, report, or summary concerning the nature, causation, and aggravation of petitioner’s injury or illness that is contained in a medical record. Section 13(b)(1). “Medical records, in general, warrant consideration as trustworthy evidence. The records contain information supplied to or by health professionals to facilitate diagnosis and treatment of medical conditions. With proper treatment hanging in the balance, accuracy has an extra premium. These records are also generally contemporaneous to the medical events.” Cucuras v. Sec’y of Health & Human Servs., 993 F.2d 1525, 1528 (Fed. Cir. 1993). Accordingly, where medical records are clear, consistent, and complete, they should be afforded substantial weight. Lowrie v. Sec’y of Health & Human Servs., No. 03- 1585V, 2005 WL 6117475, at *20 (Fed. Cl. Spec. Mstr. Dec. 12, 2005). However, this rule does not always apply. In Lowrie, the special master wrote that “written records which are, themselves, inconsistent, should be accorded less deference than those which are internally consistent.” Lowrie, 2005 WL 6117475, at *19 (quoting Murphy v. Sec’y of 3 Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 4 of 7 Health & Human Servs., 23 Cl.Ct. 726, 733 (1991), aff'd per curiam, 968 F.2d 1226 (Fed.Cir.1992)). The United States Court of Federal Claims has recognized that “medical records may be incomplete or inaccurate.” Camery v. Sec’y of Health & Human Servs., 42 Fed. Cl. 381, 391 (1998). The Court later outlined four possible explanations for inconsistencies between contemporaneously created medical records and later testimony: (1) a person’s failure to recount to the medical professional everything that happened during the relevant time period; (2) the medical professional’s failure to document everything reported to her or him; (3) a person’s faulty recollection of the events when presenting testimony; or (4) a person’s purposeful recounting of symptoms that did not exist. La Londe v. Sec’y of Health & Human Servs., 110 Fed. Cl. 184, 203-04 (2013), aff’d, 746 F.3d 1334 (Fed. Cir. 2014). The Court has also said that medical records may be outweighed by testimony that is given later in time that is “consistent, clear, cogent, and compelling.” Camery, 42 Fed. Cl. at 391 (citing Blutstein v. Sec’y of Health & Human Servs., No. 90-2808, 1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998). The credibility of the individual offering such testimony must also be determined. Andreu v. Sec’y of Health & Human Servs., 569 F.3d 1367, 1379 (Fed. Cir. 2009); Bradley v. Sec’y of Health & Human Servs., 991 F.2d 1570, 1575 (Fed. Cir. 1993). The special master is obligated to fully consider and compare the medical records, testimony, and all other “relevant and reliable evidence contained in the record.” La Londe, 110 Fed. Cl. at 204 (citing § 12(d)(3); Vaccine Rule 8); see also Burns v. Sec’y of Health & Human Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (holding that it is within the special master’s discretion to determine whether to afford greater weight to medical records or to other evidence, such as oral testimony surrounding the events in question that was given at a later date, provided that such determination is rational). IV. Finding of Fact I make the following findings after a complete review of the record to include all medical records, affidavits, Respondent’s Rule 4 report, and additional evidence filed. Specifically, I base the findings on the following evidence discussed below. • Ms. Harper received at Tdap vaccination in her left deltoid on December 29, 2016. She was 29 weeks pregnant. Ex. 10 at 1; 4 Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 5 of 7 • On January 8, 2017, Petitioner went to the emergency room reporting left shoulder pain “that began 10 days ago after receiving the Tdap vaccine.” Ex. 2 at 68. Petitioner was found to have limited range of motion of the left upper arm and shoulder, and was admitted to the hospital. Ex. 2 at 44-45; • Kenneth Ham, MD conducted an orthopedic evaluation on January 9, 2017 and assessed Petitioner with “reactive rotator cuff impingement, bursitis.” Pet. Ex. 5 at 3-4. It was noted that Petitioner experienced “pain in the left shoulder following a pertussis vaccination to her left shoulder region. The patient noted aching pain that increased and became intense from which she had trouble lifting.” Ex. 5 at 3. Petitioner was discharged on January 11, 2017. Ex. 2 at 77-78; • Petitioner was evaluated on January 17, 2017 at her obstetrician’s office for left shoulder pain. Her arm was noted to be in a sling. Petitioner reported she was advised at the hospital she had bursitis and a rotator cuff impingement due to the Tdap vaccination being administered “too high.” Ex. 6 at 93. Petitioner indicated that surgery was recommended, but that she postponed shoulder surgery until after delivery of the baby. Ex. 6 at 93; • On February 11, 2017, Petitioner delivered her baby via cesarean section. Ex. 4 at 134-135; • On April 19, 2017, Petitioner was seen by her primary provider for a sore throat and received a strep test. Ex. 11 at 24-26. No report of shoulder pain was detailed in this record; • On June 2, 2017, Petitioner was admitted to hospital for acute back pain and a urinary tract infection. Ex. 2 at 389. Petitioner was discharged on June 4, 2017 with diagnosis of acute back pain and urinary tract infection. Id. No report of shoulder pain was detailed in this record; • On September 7, 2017, Petitioner was seen by her primary care provider for left shoulder pain “for the last 20-30 days.” Ex. 3 at 3. A history was provided detailing Petitioner’s receipt of a Tdap vaccine high in her shoulder when she was six months pregnant, followed by admittance to the emergency room, and recommended surgery and physical therapy after delivery. Id. Petitioner recounted that she had been on medication as a result of her cesarean section and that her shoulder pain had dissipated but was now continuous. Id. On exam, Petitioner’s active range of motion was 5 Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 6 of 7 limited in her left shoulder and her strength was less than her right. Ex. 3 at 5. Petitioner was referred to an orthopedist. Id.; • On October 4, 2017, Petitioner was evaluated by orthopedist, Ram Aribindi, MD “complaints of left shoulder pain since December 2016. She had noted this pain after a Tdap injection.” Ex. 13 at 1. Petitioner was assessed with “left shoulder pain with limited active motion of the shoulder with tendinitis of the shoulder.” Id. Petitioner received a steroid injection. Id. at 2; • On March 13, 2018, Petitioner was seen by her primary care provider for her left shoulder pain. Her history of shoulder pain and related hospitalization when she was pregnant was provided, as well as the recommendation she undergo surgery and physical therapy post-delivery. Petitioner indicated it was not convenient to have surgery now with a one year old. Ex. 11 at 6. On exam Petitioner exhibited severely decreased passive range of motion of left shoulder. Ex. 11 at 8. An MRI and physical therapy were recommended. Id. at 8-9. In this case, it is undisputed that Petitioner received a Tdap vaccination on December 29, 2016 in her left deltoid. Respondent also has not raised any dispute concerning the onset of Petitioner’s left shoulder pain, and there is preponderant evidence that the onset of her pain was immediate after receipt of her Tdap vaccination. Ex. 2 at 44-45. Further, I find, based on the above medical records that Petitioner suffered the sequela of her shoulder injury for more than six months after her December 29, 2016 Tdap vaccination. Although, Petitioner’s September 7, 2017 visit to her primary care provider indicates left shoulder pain “for the last 20-30 days” the record for that visit also provides a “History of “Present Illness” that describes Petitioner’s receipt of a Tdap vaccination when she was six months pregnant and emergency room visit due to her pain in her shoulder followed by a diagnosis of shoulder bursitis and discharge. Ex. 3 at 3. The record of that visit further details Petitioner’s receipt of medication after her C-section and corresponding reduction in pain. Id. This record is consistent with Petitioner’s affidavits. Petitioner avers in her affidavits that after her C-section surgery she received pain medication, Norco, which helped her shoulder pain. Petitioner further explained that while she continued to experience pain between mid-January and September 2017, and that she wore an arm sling much of the time after her Norco was exhausted. During the summer after her baby was delivered, her mother and two friends were able to provide help with her home and her son. However, in September once she no longer had assistance and as her son began 6 Case 1:18-vv-00202-UNJ Document 56 Filed 12/02/20 Page 7 of 7 to move about more, Petitioner sought further medical care. Exs. 7, 15, 17. Thus, although some intervening records do not record continuous, post-vaccination pain, the records do support the conclusion (bulwarked in this case by Petitioner’s sworn statements) that she continued to experience pain throughout, if intermittently. Accordingly, I find that preponderant evidence establishes that Petitioner suffered the sequela of her alleged vaccine injury for more than six months after her December 29, 2016 Tdap vaccination. Respondent shall file his Supplemental Rule 4 Report by no later than November 11, 2020. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 7 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_18-vv-00202-1 Date issued/filed: 2020-12-16 Pages: 2 Docket text: PUBLIC ORDER/RULING (Originally filed: 11/16/2020) regarding 53 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-00202-UNJ Document 58 Filed 12/16/20 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-202V UNPUBLISHED MILAN HARPER, Chief Special Master Corcoran Petitioner, Filed: November 16, 2020 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Ruling on Entitlement; Table Injury; HUMAN SERVICES, Tetanus Diphtheria acellular Pertussis (Tdap) Vaccine; Shoulder Respondent. Injury Related to Vaccine Administration (SIRVA) Michael Patrick Milmoe, Law Offices of Leah V. Durant, PLLC, Washington, DC, for Petitioner. Mark Kim Hellie, U.S. Department of Justice, Washington, DC, for Respondent. RULING ON ENTITLEMENT1 On February 8, 2018, Milan Harper filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that that she suffered a Shoulder Injury Related to Vaccination Administration (“SIRVA”) as a result of her December 29, 2016 tetanus- diphtheria-acellular pertussis vaccine. Petition at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters. 1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-00202-UNJ Document 58 Filed 12/16/20 Page 2 of 2 On October 28, 2020, I issued a Finding of Fact wherein I found that Petitioner suffered the sequela of her alleged SIRVA for more than six months as required by Section 11(c)(1)(D)(i) of the Vaccine Act. ECF No. 51. In reaction, on November 9, 2020, Respondent filed a Supplemental Rule 4(c) Report indicating that he “has elected not to defend this case” after further review of the facts, medical records, and my Finding of Fact. ECF No. 52 at 5 - 6. Respondent further indicated that as stated in his initial Rule 4 Report: DICP [Division of Injury Compensation Programs, Department of Health and Human Services] determined that petitioner’s medical course is consistent with a shoulder injury related to vaccine administration (“SIRVA”) as defined by the Vaccine Injury Table. Specifically, petitioner had no recent history of pain, inflammation, or dysfunction of her left shoulder, pain occurred within 48 hours after receipt of an intramuscular vaccination, pain was limited to the shoulder where the vaccine was administered, and no other condition or abnormality, such as brachial neuritis, has been identified to explain petitioner’s shoulder pain. 42 C.F.R. § 100.3(a); 42 C.F.R. § 100.3(c)(10). ECF No. 52 at n. 13. In view of Respondent’s position and the evidence of record, I find that Petitioner is entitled to compensation. A Damages Order will issue. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master ================================================================================ DOCUMENT 3: USCOURTS-cofc-1_18-vv-00202-2 Date issued/filed: 2021-11-09 Pages: 8 Docket text: PUBLIC DECISION (Originally filed: 10/08/2021) regarding 73 DECISION of Special Master, Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 1 of 8 CORRECTED In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-202V UNPUBLISHED MILAN HARPER, Chief Special Master Corcoran Petitioner, Filed: October 8, 2021 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Decision Awarding Damages; Pain HUMAN SERVICES, and Suffering; Tetanus Diphtheria acellular Pertussis (Tdap) Vaccine; Respondent. Shoulder Injury Related to Vaccine Administration (SIRVA) Michael Patrick Milmoe, Law Offices of Leah V. Durant, PLLC, Washington, DC, for Petitioner. Colleen Clemons Hartley, U.S. Department of Justice, Washington, DC, for Respondent. DECISION AWARDING DAMAGES1 On February 8, 2018, Milan Harper filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a Table Injury – a Shoulder Injury Related to Vaccine Administration (“SIRVA”) – as a result of a Tetanus Diphtheria acellular Pertussis (“Tdap”) vaccine received on December 29, 2016. Petition, ECF No. 1 at 1. The case was assigned to the Special Processing Unit of the Office of Special Masters (the “SPU”). The parties could not agree on damages, so the disputed component of pain and suffering was submitted to SPU Motions Day. 1 Because this Decision contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 2 of 8 For the reasons described below, and after holding a brief hearing in this matter, I find that Petitioner is entitled to an award of damages in the amount $92,000.00, representing compensation for her actual pain and suffering. I. Procedural Overview As noted above, the case was initiated in February 2018. Respondent filed a Rule 4(c) Report arguing that Petitioner’s case should be dismissed for failure to satisfy the “threshold severity requirement” that Petitioner suffered the residual effects of her alleged vaccine-related injury for more than six months after vaccination. ECF No. 36. On October 28, 2020, I issued a Finding of Fact, however, determining that Petitioner had established severity in conformance with Section 11(c)(1)(D)(i) of the Vaccine Act. ECF No. 51. In reaction, on November 10, 2020, Respondent filed a Supplemental Rule 4(c) Report indicating that he “has elected not to defend this case” after further review of the facts, medical records, and my Finding of Fact. ECF No. 52 at 5 – 6. I therefore issued a Ruling on Entitlement on November 16, 2020, finding Petitioner entitled to compensation for her SIRVA. ECF No. 53. The parties were subsequently unable to informally resolve the issue of damages, so a briefing schedule was set on March 17, 2021. ECF No. 63. Petitioner filed her brief on May 22, 2021, requesting that I award her $120,000.00 in compensation - representing her past/actual pain and suffering. ECF No. 66. Conversely, in a brief filed on July 16, 2021, Respondent argued that Petitioner should be awarded only $77,500.00 for past pain and suffering. ECF No. 69. Petitioner filed a Reply brief on August 2, 2021. ECF No. 70. (The parties have otherwise agreed upon an award of $4,185.03 representing Petitioner’s unreimbursed expenses, so that amount is not disputed and will be awarded as well). In August of this year, I informed the parties that this case was appropriate for an expedited hearing and ruling via my “Motions Day” practice, at which time I would decide the disputed damages issues based on all evidence filed to date plus whatever oral argument they wanted to make. ECF No. 71. The parties agreed, and an expedited hearing took place on September 24, 2021. Minute Entry dated October 1, 2021.3 I orally ruled on Petitioner’s damages at that time, and this Decision memorializes my determination. 3 Michael Milmoe appeared on behalf of Petitioner, and Colleen Hartley appeared on behalf of Respondent. The transcript of the September 24, 2021 Hearing in this case was not filed as of the date of this Decision, but my oral ruling is incorporated by reference herein. 2 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 3 of 8 II. Pain and Suffering A. Legal Standard and Prior SIRVA Pain and Suffering Awards In another recent decision, I discussed at length the legal standard to be considered in determining damages and prior SIRVA compensation within SPU. I fully adopt and hereby incorporate my prior discussion in Sections II and III of Berge v. Sec’y Health & Human Servs., No. 19-1474V, 2021 WL 4144999, at *1-3. (Fed. Cl. Spec. Mstr. Aug. 17, 2021). In sum, compensation awarded pursuant to the Vaccine Act shall include “[f]or actual and projected pain and suffering and emotional distress from the vaccine-related injury, an award not to exceed $250,000.” Section 15(a)(4). The petitioner bears the burden of proof with respect to each element of compensation requested. Brewer v. Sec’y of Health & Human Servs., No. 93-0092V, 1996 WL 147722, at *22-23 (Fed. Cl. Spec. Mstr. Mar. 18, 1996). Factors to be considered when determining an award for pain and suffering include: 1) awareness of the injury; 2) severity of the injury; and 3) duration of the suffering.4 B. Appropriate Compensation for Petitioner’s Pain and Suffering In this case, Ms. Harper’s awareness of the injury is not disputed, leaving only the severity and duration of that injury to be considered. In determining appropriate compensation for pain and suffering, I have carefully reviewed and taken into account the complete record in this case, including, but not limited to: Petitioner’s medical records, affidavits, filings, and all assertions made by the parties in written documents and at the expedited hearing held on September 24, 2021. I have also considered prior awards for pain and suffering in both SPU and non-SPU SIRVA cases, and relied upon my experience adjudicating these cases. However, my determination is ultimately based upon the specific circumstances of this case. The record establishes that Petitioner’s shoulder pain was initially quite severe prompting her to go the emergency room on January 8, 2017, only ten days after her vaccination. Ex. 2 at 68. Significantly, at that time she was 31-weeks pregnant. Id. She reported that her shoulder pain began after receipt of her Tdap vaccine and had progressed to the point where she could not lift her upper left extremity. Id. She was 4 I.D. v. Sec’y of Health & Human Servs., No. 04-1593V, 2013 WL 2448125, at *9 (Fed. Cl. Spec. Mstr. May 14, 2013) (quoting McAllister v. Sec’y of Health & Human Servs., No 91-1037V, 1993 WL 777030, at *3 (Fed. Cl. Spec. Mstr. Mar. 26, 1993), vacated and remanded on other grounds, 70 F.3d 1240 (Fed. Cir. 1995)). 3 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 4 of 8 transferred to the Labor and Delivery Department of the hospital and admitted for observation. Ex. 2 at 44, 89. The following day she received orthopedic evaluation from Kenneth Ham, MD, who assessed Petitioner with “reactive rotator cuff impingement, bursitis.” Pet. Ex. 5 at 3-4. It was noted that Petitioner had experienced “pain in the left shoulder following a pertussis vaccination to her left shoulder region. The patient noted aching pain that increased and became intense from which she had trouble lifting.” Ex. 5 at 3. She was discharged from the hospital after four days. Ex. 2 at 77-78. Thereafter, she underwent intermittent treatment for her shoulder injury for approximately three years. However, the record also establishes that Ms. Harper suffered on balance a moderately severe injury. After her discharge from the hospital, Petitioner was evaluated at her obstetrician’s office on January 17, 2017 for left shoulder pain. Her arm was noted to be in a sling at that time. Ex. 6 at 93. Petitioner indicated that surgery had been recommended to her, but that she postponed shoulder surgery until after delivery of the baby. Ex. 6 at 93. On February 11, 2017, Petitioner gave birth after undergoing a cesarean section. Ex. 4 at 134. Subsequently, Petitioner had two appointments for post-partum care by her obstetrician on March 1, 2017 and April 5, 2017 (Ex. 20 at 73-76, 81-84), an examination by her primary care physician on April 19, 2017 for a sore throat (Ex. 11 at 24-26), and was seen in emergency room on June 2, 2017 for back pain and admitted to the hospital (Ex. 2 at 389). Petitioner was discharged from the hospital on June 4, 2017 with a diagnosis of acute low back pain and a urinary tract infection. Id. Significantly, none of these medical records documented any complaints of left shoulder pain. Petitioner sought follow-up care for her shoulder pain with her primary care provider on September 7, 2017 – nearly eight months since she had last sought treatment, and approximately seven months after the birth of her son. Ex. 3 at 3-6. Her primary care provider detailed Petitioner’s history of receipt of a Tdap vaccine high in her shoulder when she was six months pregnant, followed by admittance to the hospital two weeks later. Id. at 3. Petitioner indicated she was advised to undergo surgery and physical therapy after her delivery of her baby. Id. Petitioner reported that she had been on medication as a result of her cesarean section and that her shoulder pain had “dissipated,” but that the pain was now “continuous”, and she was taking ibuprofen. Id. On exam, Petitioner’s active range of motion was limited in her left shoulder and her strength was less than her right. Ex. 3 at 5. Petitioner was referred to an orthopedist and advised to take “Tylenol/Motrin as needed” and to “use heating pad” to treat her left shoulder pain. Id. Petitioner followed-up one month later with an orthopedist, Ram Aribindi, MD, on October 4, 2017. Ex. 13 at 1. Dr. Aribindi indicated Petitioner had “complaints of left shoulder pain noted since December 2016” following her Tdap 4 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 5 of 8 injection. Id. Petitioner was assessed with left shoulder pain and “limited active motion of the shoulder with tendinitis” and administered a steroid injection to treat her shoulder pain. Id. at 1-2. Subsequently, Petitioner next sought treatment with her primary care provider five months later on March 13, 2018. Ex. 11 at 6. Petitioner’s history of shoulder pain was related, as well as the recommendation she undergo surgery and physical therapy post- delivery. Petitioner indicated it was not convenient to have surgery now with a one-year- old. Ex. 11 at 6. On exam Petitioner exhibited severely decreased passive range of motion of left shoulder. Ex. 11 at 8. An MRI and physical therapy were recommended. Id. at 8-9. However, Petitioner did not undergo an MRI or engage in physical therapy. Ten more months passed before Ms. Harper again sought treatment for her SIRVA, this time on January 7, 2019 from Oh J. Lee, MD. She requested that Dr. Lee provide her with a referral to an orthopedic specialist for a steroid injection – Dr. Lee provided her the referral and recommended she receive physical therapy. Ex. 16 at 1-2. No records have been filed evidencing that Petitioner ever followed up with an orthopedic surgeon or received a steroid injection. The only subsequent reference to Petitioner’s shoulder pain occurs eleven months later, on December 6, 2019, when Petitioner sought a fertility referral from Dr. Lee, the notes from this visit indicate “left shoulder had a shot5 with better [sic], and taking ibuprofen [as needed].” Ex. 16 at 3. While I do not conclude from this record that Petitioner had completely recovered from her shoulder injury at that point, I find that her SIRVA and related sequela had significantly improved. No further treatment records have been filed that would document additional treatment. 6 Also bearing on the pain and suffering sum to be awarded are Petitioner’s multiple sworn affidavits (Exs. 7, 15, 17, 23), as well as those provided by her family members (Exs. 24-26), all of which fill in the gaps between Petitioner’s limited medical appointments. The affidavits detail the intense pain Petitioner felt following her vaccination (which she retrospectively rates in her May 7, 2021 affidavit as 10/10, and then 7/10 for all of 2017). See, e.g., Ex. 7 ¶ 3, Ex. 23 ¶ 2. Petitioners’ affidavits further detail how her pain limited her ability to care for, and be active with her oldest son, born only months following her injury, as well as her second child born in 2020. E.g., Ex. 23 ¶¶ 2, 5. This caused Petitioner to undergo unique suffering as she sought for many years to become a mother. E.g., Ex. 23 ¶ 1. 5 The records indicate Petitioner received only one steroid injection to treat her shoulder pain, notwithstanding Dr. Lee’s referral on January 7, 2019 to an orthopedic surgeon for a steroid injection. 6 Petitioner’s counsel confirmed in May 2021 that Petitioner has no updated medical records outstanding. Informal Communication dated May 24, 2021. 5 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 6 of 8 In addition, the affidavits detail other limitations experienced by Petitioner over the course of her injury, including: difficulty sleeping, preforming household chores (such as carrying groceries, washing dishes, and doing laundry), and driving. E.g., Ex. 7 ¶ 10, Ex. 23 ¶ 3. Petitioner details how she has had to rely on the use of a sling, ibuprofen, Tylenol, an adjustable bed, CBD oil, and a TENS machine to manage flare-ups of shoulder pain. E.g., Ex. 23 ¶ 6. Additionally, Petitioner explains how as a result of her shoulder pain she was forced to reply upon her husband, mother, sister-in-law, for assistance with household chores and the care of her children. E.g., Ex. 15 ¶ 7, Ex. 23 ¶¶ 2, 6. Finally, the affidavits address the gaps in Ms. Harper’s treatment. Petitioner explains that post-delivery of her first child she was initially able to manage her shoulder pain with the use of Norco she received after her cesarean section, and then with childcare assistance provided by her mother. E.g., Ex. 15 ¶¶ 3-4. Later, she explains she did not engage in physical therapy or undergo surgery, because she was advised that at least initially these interventions would increase her pain and she indicates that could not bear further pain. E.g., Ex. 17 ¶ 3. Further, Petitioner explains that she did not seek additional treatment as she was focused on the care of her family, including children with their own medical issues, and that her family was also financially constricted with poor insurance coverage. E.g., Ex. 17, ¶ 3, Ex. 23 ¶4. Additionally, Petitioner’s husband explains in his affidavit that Petitioner believes she can “tough everything out and would go to the doctor [at] the very last minute when the pain is unbearable” and she had “exhausted all options.” Ex. 24 at ¶ 5. Based upon all of the above, Petitioner has offered adequate record substantiation for a pain and suffering award higher than that recommended by Respondent. The affidavits in particular were helpful in illuminating the paucity of medical treatment overall. However (and informed by my experience adjudicating SIRVA claims), I also note that severe SIRVA injuries usually necessitate ongoing treatment and/or intrusive and time- intensive medical interventions (such as surgery, multiple steroid injections, and physical therapy). Petitioners living with such persistent pain will seek out this level of treatment despite considerations like cost or competing personal obligations – and it is reasonably inferred from treatment lapses or gaps that severity was somewhat lower. See, e.g., Dirksen v. Sec’y of Health & Hum. Servs., No. 16-1461V, 2018 WL 6293201, at *9-10 (Fed. Cl. Spec. Mstr. Oct. 18, 2018) (treatment gaps are “a relevant consideration in determining the degree of petitioner’s pain and suffering”). Accordingly, in this case the gaps in treatment, and lack of medical visits and/or formal medical interventions, support an award lower than that requested by Petitioner. Petitioner argues that her case is comparable to two other SIRVA decisions not involving surgery. See Binette v. Sec’y of Health & Hum. Servs., No. 16-0731V, 2019 WL 1552620 (Fed. Cl. Spec. Mstr. Mar. 20, 2019) (awarding $130,000.00 for actual pain and 6 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 7 of 8 suffering, and $1,000.00 per year for projected pain and suffering); Cooper v. Sec’y Health & Hum. Servs., No. 16-1387V, 2018 WL 6288181 (Fed. Cl. Spec. Mstr. Nov. 7, 2018) (awarding $110,000.00 for actual pain and suffering). But these cases are factually distinguishable. The Binette petitioner underwent two rounds of physical therapy (approximately 25 sessions) to treat her injury and received five steroid injections. Binette, 2019 WL 1552620, at *5-6,13. Additionally, the Binette petitioner’s injury was deemed surgically inoperable. Id. The Cooper case, like the instant matter, involved a gap in medical treatment and no MRI evidence, but the Cooper petitioner also underwent a significant amount of physical therapy – approximately 35 physical therapy sessions – in addition the Cooper petitioner sought chiropractic care, acupuncture, and massage therapy. Cooper, 2018 WL 6288181, at *3-8, 12-13. I thus find the awards in these cases exceed what is appropriate here. However, I also find that Petitioner’s injury was more severe than the two cases primarily cited by Respondent in support of his proposed award. Knauss v. Sec’y Health & Hum. Servs., No. 16-1372V, 2018 WL 3432906 (Fed. Cl. Spec. Mstr. May 23, 2018) (awarding $60,000.00 for actual pain and suffering); Dagen v. Sec’y of Health & Hum. Servs., No. 18-0442V, 2019 WL 7187335 (Fed. Cl. Spec. Mstr. Nov. 6, 2019) (awarding $65,000.00 for actual pain and suffering). Rather, I find the instant case most comparable to the Desrosiers case – acknowledged by Respondent in a footnote within his damages brief. Desrosiers v. Sec’y Health & Human Servs., No. 16-0224V, 2017 WL 5507804 (Fed. Cl. Spec. Mstr. Sept. 19, 2017) (awarding $85,000.00 for past pain and suffering). While the Desrosiers petitioner did undergo some physical therapy, it was not as extensive as the physical therapy undertaken by the Cooper or Binette petitioners. Desrosiers also involved a petitioner who was pregnant at the onset of her SIRVA – like Ms. Harper. Ultimately, I determine that an award higher than that in Desrosiers is most appropriate. Ms. Harper suffered a somewhat more severe injury than that in Desrosiers, despite the gaps in her treatment, particularly given her four-day hospitalization following the initial onset of her shoulder pain. Conclusion Based on the record as a whole and arguments of the parties, I award Petitioner a lump sum payment of $96,185.03, representing $92,000.00 in compensation for her actual pain and suffering, plus $4,185.03 for Petitioner’s unreimbursed expenses. This amount represents compensation for all damages that would be available 7 Case 1:18-vv-00202-UNJ Document 76 Filed 11/09/21 Page 8 of 8 under Section 15(a). The Clerk of the Court is directed to enter judgment in accordance with this decision.7 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 7 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 8